Case series of AML patients receiving hypomethylation therapy and retrospectively found to have IDH1 or IDH2 mutations

Podobne knjige/članki

• Prognostic Significance of Alterations in IDH Enzyme Isoforms in Patients With AML Treated With High Dose Cytarabine and Idarubicin
  od: Ravandi, Farhad, et al.
  Izdano: (2011)
• Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML
  od: DiNardo, Courtney D., et al.
  Izdano: (2015)
• Lack of association of IDH1, IDH2, and DNMT3A mutations with outcome in older patients with AML treated with hypomethylating agents
  od: DiNardo, CD, et al.
  Izdano: (2014)
• Clofarabine plus low-dose cytarabine is as effective as and less toxic than intensive chemotherapy in elderly AML patients
  od: Takahashi, Koichi, et al.
  Izdano: (2015)
• TREATMENT WITH FLT3 INHIBITOR IN PATIENTS WITH FLT3-MUTATED AML IS ASSOCIATED WITH DEVELOPMENT OF SECONDARY FLT3-TKD MUTATIONS
  od: Alvarado, Yesid, et al.
  Izdano: (2014)